Gould Robert J insider trades
Gould Robert J has filed 14 Form 4s with the SEC that we hold, for Fulcrum Therapeutics, Inc. (FULC) (Director) and TSBX (Director). Across all of them we count 0 purchases worth $0 and 12 sales worth $4.1M reported on Form 4. In the last 12 months: 0 purchases ($0) and 3 sales ($489.3K). The largest single trade was a sale of 52,552 shares of Fulcrum Therapeutics, Inc. worth $1.3M, dated 2022-04-05. The first filing on our record is dated 2022-04-05 and the latest 2026-07-02.
Fulcrum Therapeutics, Inc. (FULC)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-04-01 | S, sale reported on Form 4 | 34,464 | $828.2K | 2022-04-05 |
| 2022-04-04 | S, sale reported on Form 4 | 7,235 | $173.8K | 2022-04-05 |
| 2022-04-05 | S, sale reported on Form 4 | 52,552 | $1.3M | 2022-04-05 |
| 2022-04-07 | S, sale reported on Form 4 | 5,631 | $135.3K | 2022-04-11 |
| 2022-06-02 | S, sale reported on Form 4 | 16,689 | $132.2K | 2022-06-06 |
| 2022-06-03 | S, sale reported on Form 4 | 25,551 | $203.1K | 2022-06-06 |
| 2022-06-06 | S, sale reported on Form 4 | 24,382 | $197.5K | 2022-06-06 |
| 2022-06-07 | S, sale reported on Form 4 | 71,435 | $577.9K | 2022-06-08 |
| 2023-01-13 | S, sale reported on Form 4 | 6,766 | $101.5K | 2023-01-13 |
| 2025-11-19 | S, sale reported on Form 4 | 15,000 | $165.4K | 2025-11-21 |
| 2026-01-02 | S, sale reported on Form 4 | 15,000 | $163.1K | 2026-02-04 |
| 2026-02-02 | S, sale reported on Form 4 | 15,000 | $160.8K | 2026-02-04 |
TSBX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1577034) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms